fenofibrate
- 网络非诺贝特；弗尼利脂宁；血脂药物
fenofibratefenofibrate
非诺贝特
...文娟 综述 黄贤圣 校 中南大学湘雅二医院心内科 非诺贝特（Fenofibrate）为第二代苯氧芳酸类药物，与吉非贝齐、苯扎贝特 …
弗尼利脂宁
食品与药品交互作用知识查询平台 ... Pioglitazone( 爱妥糖) Fenofibrate( 弗尼利脂宁) Isoniazid( 异菸硷醯) ...
血脂药物
...romarone (Narcaricid) 、 抗血脂药物 (fenofibrate) 、及降血压药 (Losartan) 。
非诺贝特及片
...in)、盐酸雷洛昔芬及片(Raloxifene)、非诺贝特及片(Fenofibrate)、西立伐他汀钠及片(Cerivastatin) 盐酸精氨酸及颗粒剂(Argini…
非诺贝持
非诺贝持(Fenofibrate)为第三代苯氧乙酸类降血脂药.其结构类似安妥明,系目前国外治疗高血脂症的常用药物.商品名称立平脂(Ll…
供应非诺贝特
供应非诺贝特( Fenofibrate )供应吉非罗齐( Gemfibrozil ) 化工原材料价格/报价 精细化学品价格/报价 电子原材料价格/报价 冶金 …
非诺贝齐
...次,3 次 d 转氨酶升高偶见, 伴血尿素氮升高 非诺贝齐(fenofibrate) 平脂力, 力平脂 口服,0 .1 g 次,3 次 d 转氨酶升高偶见 吉非...
1
The study found virtually no difference in the risk for amputations above the ankle between those who did and did not take fenofibrate.
研究发现踝以上截肢风险在服用非诺贝特组和非服用非诺贝特组之间并无显著差异。
2
The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo.
初次截肢的风险非诺贝特组较安慰剂组降低了36%。
3
Compared with HG group, these changes could be fully or partly reversed by fenofibrate treatment.
与高糖组比较非诺贝特干预后能完全或部分逆转上述变化。
4
Objective: To explore the protective mechanism of fenofibrate on diabetic nephropathy.
目的：探讨非诺贝特对糖尿病肾病的保护机制。
5
In ACCORD Lipid, fenofibrate also reduced micro- and macro-albuminuria, markers of diabetic renal disease.
在ACCORD脂质研究基金会，非诺贝特同时降低了微观及宏观尿蛋白量，二者都是胰岛肾病的标志。
6
But the release of fenofibrate from Tricor? tablets or micronized fenofibrate dispersion systems (MDSs) was limited in water medium.
但是对照处方Tricor？tablets及微粉化药物分散系统于水中的溶离则受到限制。
7
This is achieved by adding fenofibrate to simvastatin.
疗效是通过将非诺贝特加入辛伐他汀里取得的。
8
Effects of fenofibrate on proliferation and apoptosis induced by lysophosphatidylcholine in cultured human umbilical vein endothelial cells
非诺贝特对溶血卵磷脂诱导的血管内皮细胞增生及凋亡的影响
9
Comparison between effect of fenofibrate sustained release pellet capsule and simvastatin in treating combined hyperlipidemia
非诺贝特微丸缓释胶囊与辛伐他汀治疗混合型高脂血症的比较
10
Fenofibrate Partly Prevents Oxidized-Low Density Lipoprotein Induced Immune Maturation of Human Monocyte-Derived Dendritic Cell
非诺贝特部分阻断氧化型低密度脂蛋白诱导的人单核细胞源树突状细胞的免疫成熟
11
Fenofibrate increases endothelial nitric oxide synthase expression in bovine aortic endothelial cells
非诺贝特上调血管内皮细胞一氧化氮合酶的表达
12
Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissues
非诺贝特对脂肪组织凝血和纤溶因子表达的影响
13
Upper gastrointestinal hemorrhage associated with concomitant use of warfarin, losartan potassium, fenofibrate and allopurinol
华法林与氯沙坦、非诺贝特及别嘌醇伍用致上消化道出血
14
Fenofibrate Inhibiting Tissue Factor Expression in Adipocytes
非诺贝特抑制脂肪细胞组织因子表达
15
Regulatory effects of pioglitazone and fenofibrate on body fat distribution and energy homeostasis in SD rats
吡格列酮和非诺贝特对SD大鼠体脂分布及能量代谢的调节作用
16
Comparison of effect of fenofibrate and rosiglitazone on levels of serum lipid, body weight and insulin sensitivity in rats
非诺贝特和罗格列酮对大鼠血脂、体重和胰岛素敏感性的作用比较
17
Effect of Polymorphism of Human Intestinal Fatty Acid Binding Protein Gene on the Therapeutic Efficacy of Fenofibrate
小肠脂肪酸结合蛋白基因多态性对非诺贝特降血脂作用的影响
18
Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus
综述非诺贝特在初期血脂障碍、代谢综合症和2型糖尿病中的应用
19
Inhibition effect of fenofibrate on vascular remodeling after coronary artery injury
非诺贝特对冠状动脉损伤后血管重构的抑制效果
20
Efficacy and safety of combined therapy with simvastatin and fenofibrate for type 2 diabetes patients with mixed hyperlipidemia
辛伐他汀联合非诺贝特治疗2型糖尿病并混合性高脂血症的疗效和安全性观察